Structure of the human protein kinase ZAK in complex with vemurafenib.
The mixed lineage kinase ZAK is a key regulator of the MAPK pathway mediating cell survival and inflammatory response. ZAK is targeted by several clinically approved kinase inhibitors, and inhibition of ZAK has been reported to protect fromdoxorubicin-induced cardiomyopathy. On the other hand, unint...
المؤلفون الرئيسيون: | Mathea, S, Abdul Azeez, K, Salah, E, Tallant, C, Wolfreys, F, Konietzny, R, Fischer, R, Lou, H, Brennan, P, Schnapp, G, Pautsch, A, Kessler, B, Turk, B, Knapp, S |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
American Chemical Society
2016
|
مواد مشابهة
-
Conformational plasticity of the ULK3 kinase domain
حسب: Mathea, S, وآخرون
منشور في: (2021) -
Computational and Functional Analysis of Structural Features in the ZAKα Kinase
حسب: Valdemar Brimnes Ingemann Johansen, وآخرون
منشور في: (2023-03-01) -
High-throughput purification of protein kinases from Escherichia coli and insect cells
حسب: Mathea, S, وآخرون
منشور في: (2019) -
LA TRANSFORMADA DE ZAK
حسب: Luis Miguel Nuñez Ramirez, وآخرون
منشور في: (2014-09-01) -
In Silico Studies of Novel Vemurafenib Derivatives as BRAF Kinase Inhibitors
حسب: Teresa Żołek, وآخرون
منشور في: (2023-07-01)